Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | 43,296 | reported | 24 Mar 2026 | tx 11+5,533,325−14,204 |
| iBio, Inc. | 13,500 | reported | 20 Nov 2025 | tx 4+241,400 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Mar 2026 | TAX_WITHHOLDING | SAB Biotherapeutics, Inc. | 988 | — | |
| 03 Feb 2026 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 2,400,000 | 0.00 USD | deriv |
| 11 Dec 2025 | TAX_WITHHOLDING | SAB Biotherapeutics, Inc. | 988 | — | |
| 20 Nov 2025 | GRANT_AWARD | iBio, Inc. | 13,500 | 0.00 USD | deriv |
| 19 Sept 2025 | TAX_WITHHOLDING | SAB Biotherapeutics, Inc. | 1,977 | — | |
| 26 Aug 2025 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 2,400,000 | 0.00 USD | deriv |
| 27 Mar 2025 | TAX_WITHHOLDING | SAB Biotherapeutics, Inc. | 1,179 | — | |
| 18 Dec 2024 | TAX_WITHHOLDING | SAB Biotherapeutics, Inc. | 9,072 | — | |
| 21 Nov 2024 | GRANT_AWARD | iBio, Inc. | 18,900 | 0.00 USD | deriv |
| 21 Feb 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 140,000 | 0.00 USD | deriv |
| 14 Mar 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 275,000 | — | |
| 13 Sept 2022 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 18,325 | 0.00 USD | deriv |
| 06 Jun 2022 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 300,000 | 0.00 USD | |
| 09 Dec 2021 | GRANT_AWARD | iBio, Inc. | 109,000 | 0.00 USD | deriv |
| 14 Oct 2020 | GRANT_AWARD | iBio, Inc. | 100,000 | 0.00 USD | deriv |